Detalles de la búsqueda
1.
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.
Gynecol Oncol
; 173: 130-137, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148580
2.
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Lancet Oncol
; 23(8): e374-e384, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35901833
3.
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
N Engl J Med
; 381(25): 2403-2415, 2019 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562800
4.
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study.
Gynecol Oncol
; 165(1): 97-104, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35153073
5.
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial.
Gynecol Oncol
; 164(2): 278-287, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34930617
6.
Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.
Gynecol Oncol
; 164(2): 245-253, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34906376
7.
Progression-free survival by investigator versus blinded independent central review in newly diagnosed patients with high-grade serous ovarian cancer: Analysis of the VELIA/GOG-3005 trial.
Gynecol Oncol
; 162(2): 375-381, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34112513
8.
Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer.
Gynecol Oncol
; 163(2): 254-261, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34474927
9.
Can we predict who lives long with ovarian cancer?
Cancer
; 125 Suppl 24: 4578-4581, 2019 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31967684
10.
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
Gynecol Oncol
; 154(2): 420-425, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31229298
11.
Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer.
Am J Obstet Gynecol
; 221(6): 625.e1-625.e14, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31207237
12.
Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 151(1): 18-23, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30135020
13.
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
Gynecol Oncol
; 148(1): 49-55, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174555
14.
What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
Cancer
; 123(6): 985-993, 2017 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864921
15.
Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer.
Gynecol Oncol
; 146(1): 58-63, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454659
16.
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 147(2): 396-401, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935272
17.
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Gynecol Oncol
; 147(2): 243-249, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28807367
18.
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Gynecol Oncol
; 143(1): 3-15, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27650684
19.
Sister Society Meeting on Global Education Development and Collaboration: Meeting Report.
Int J Gynecol Cancer
; 26(6): 1186-8, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27327155
20.
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study.
Gynecol Oncol
; 139(1): 17-22, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26216729